ARARIS BIOTECH AG

Summary

Araris Biotech specializes in developing antibody-drug conjugates (ADCs) for targeted cancer therapy.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 881 M

Avg. Deal Size£ 881 M

Market Context

Senior Management